1. Digitum: Repositorio Institucional de la Universidad de Murcia

Buscar por Autor Alonso-Romero, José Luis

Ir a una fecha de inicio:
Mostrando resultados 1 a 20 de 23  Siguiente >
Vista previaFecha de publicaciónFecha de CreaciónTítulo
A_1006062018355.pdf.jpg1998-Weekly continuous infusion of 5-fluorouracil with oral leucovorin in metastatic breast cancer patients with primary resistance to doxorubicin
nieto-et-al-1998-end-stage-acute-hepatic-failure-as-clinical-presentation-of-liver-metastases-from-breast-cancer.pdf.jpg1998-End-stage acute hepatic failure as clinical presentation of liver metastases from breast cancer
1-s2.0-S0025775304743456-main.pdf.jpg2004-Neoplasias primarias del timo de estirpe no linfoide. Estudio de 58 casos
1-s2.0-S0009739X08721559-main.pdf.jpgsep-2008-Características inmunohistoquímicas del cáncer de mama: ¿hacia una nueva clasificación?
s12094-009-0390-2.pdf.jpgjul-2009-Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)
WJOG-2-21.pdf.jpg10-may-2013-Past, present and future of primary systemic treatment in breast cancer
s10689-014-9708-5.pdf.jpg16-mar-2014-Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry
s10689-017-9985-x.pdf.jpg5-may-2017-Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical–pathological features in BRCA carriers and non-carriers
s12094-017-1732-0.pdf.jpg7-ago-2017-Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy
s12964-017-0205-y.pdf.jpg29-nov-2017-Sirt1 interaction with active Smad2 modulates transforming growth factor-β regulated transcription
1-s2.0-S1769721217303932-main.pdf.jpg2-feb-2018-Mutational analysis of RAD51C and RAD51D genes in hereditary breast and ovarian cancer families from Murcia (southeastern Spain)
1-s2.0-S2210776217304507-main.pdf.jpg23-jun-2018-New insights into the performance of multigene panel testing: two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer
fendo-09-00552.pdf.jpg27-sep-2018-SIRT1 and estrogen signaling cooperation for breast cancer onset and progression
PIIS0923753420403898.pdf.jpg2020-Trastuzumab emtansine in HER2-positive metastatic breast cancer after pertuzumab and trastuzumab: TDM1RM Study
Immunoscore a novel prognostic tool. Association with clinical outcome response to treatment and survival in several malignancies.pdf.jpg16-mar-2020-Immunoscore: a novel prognostic tool. Association with clinical outcome, response to treatment and survival in several malignancies
Analysis_of_adolescent_oncology_cases_from_2008_th.pdf.jpg25-feb-2021-Analysis of adolescent oncology cases from 2008 through 2018 in a tertiary-level hospital: an opportunity for improvement
cancers-13-05432.pdf.jpg29-oct-2021-Pembrolizumab plus gemcitabine in the subset of triple-negative advanced breast cancer patients in the GEICAM/2015-04 (PANGEA-Breast) study
s10434-021-11087-7.pdf.jpg23-nov-2021-Cytoreductive surgery with or without HIPEC After neoadjuvant chemotherapy in ovarian cancer: a phase 3 clinical trial
1107.pdf.jpg3-ene-2022-Sapanisertib plus Fulvestrant in postmenopausal women with estrogen receptor–positive/HER2-negative advanced breast cancer after progression on aromatase inhibitor
1-s2.0-S1769721222000490-main.pdf.jpg1-mar-2022-Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance
Mostrando resultados 1 a 20 de 23  Siguiente >